[1]
T. Dalkh, N. Naranbat, E. Bayarsaikhan, T.-A. Damba, and T. Byambaaa, “Effects of Hepaclin-4 on Hepatocellular Carcinoma (Hep G2)”, Cent. Asian j. Med. Sci., vol. 4, no. 1, pp. 48–54, Mar. 2018.